| Financial Year |
March 31 2023 |
| Monetary Funds |
1,506,856,033.45 |
| Held-for-trading Financial Assets |
229,439,926.02 |
| Notes Receivable |
69,278,335.85 |
| Accounts Receivable |
2,083,319,323.43 |
| Advances to Suppliers |
195,741,946.27 |
| Other Receivables |
166,294,516.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
10,000,000.00 |
| Inventories |
1,437,796,605.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,995,071.68 |
| Other Current Assets |
47,291,967.90 |
| Total Current Assets |
6,734,178,289.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,268,701.12 |
| Long-term Equity Investment |
3,590,698,892.61 |
| Investment Properties |
103,565,661.70 |
| Fixed Assetes |
2,877,327,025.73 |
| Under-construction Projects |
342,328,708.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
632,489,164.38 |
| R&D expenses |
-- |
| Goodwill |
10,421,262.66 |
| Long-Term Deferred and Prepaid Expenses |
75,995,248.43 |
| Deferred Income Tax Assets |
243,858,505.61 |
| Other Non-Current Assets |
153,712,630.58 |
| Sub-Total of Non-Current Assets |
8,212,875,353.07 |
| Total Assets |
14,947,053,642.73 |
| Short-Term Loans |
59,041,250.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,351,219,864.90 |
| Accounts Payable |
2,737,424,446.69 |
| Accounts Received In Advance |
31,914,678.90 |
| Employee Compensation Payable |
89,839,370.10 |
| Taxes Payable |
30,763,587.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
462,042,998.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
43,417,863.00 |
| Other Current Liabilities |
1,270,062.80 |
| Sub-Total of Current Liabilities |
4,821,117,655.84 |
| Long-term Loans |
710,138,892.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
111,278,300.89 |
| Deferred Income Tax Liabilities |
63,284,789.84 |
| Other Non-Current Liabilities |
56,593,405.29 |
| Sub-Total of Non-Current Liabilities |
1,576,812,765.00 |
| Total Liabilities |
6,397,930,420.84 |
| Paid-In Capital(Or Share Stock) |
1,741,643,085.00 |
| Capital Surplus |
485,425,109.23 |
| Surplus Reserve |
674,906,310.08 |
| LESS:Treasury Stock |
130,002,519.40 |
| Undistributed Profits |
4,748,720,659.94 |
| Minority Stockholder's Interest |
989,349,343.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,559,773,878.71 |
| Owner's Equity（Stockholder's Equity） |
8,549,123,221.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,947,053,642.73 |
